GSK (GSK.L)
GSK is a British pharmaceutical giant that researches, develops, and manufactures vaccines and medicines to treat infectious diseases, HIV, and cancer.
Is GSK a good stock for a UK beginner?
The honest version: GSK is a British pharmaceutical giant that researches, develops, and manufactures vaccines and medicines to treat infectious diseases, HIV, and cancer.
Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. Past performance is not a guide to the future, and it could just as easily have fallen.
Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
Breakthroughs in oncology treatments capturing significant market share.
Significant legal challenges or failure to innovate effectively.
What does GSK do?
GSK focuses on the science of the immune system and genetics to create treatments that help people live longer, healthier lives. Sales of these patented medicines and vaccines to healthcare providers and governments around the world are what pay the bills. What really moves the needle here is keeping a steady pipeline of new drugs through clinical trials to replace older medicines as their patents expire.
On our factor screen it looks strongest on quality and income, and weakest on growth.
- ✓Pays a dividend - about 3.5% a year
- ✓Growing - revenue up about 5% over the year
- ✓Strong return on shareholder money (ROE 33%)
- Strong profit margins on core products
- High return on equity showing efficient use of capital
- Relatively stable share price compared to the wider market
- Growth screens low (26/100)
- Legal challenges related to past or current products
- Patent cliffs where generic competitors erode sales
- Failure of late-stage clinical trials to deliver results
What do GSK's numbers mean?
How much money does GSK make?
Revenue and profit by quarter, and how much of each sale turns into profit.
Does GSK pay a dividend?
Yes - GSK currently pays a dividend of about 3.5% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.
More in Healthcare
Eli Lilly
West Pharmaceutical Services, Inc.
Incyte Corporation
The Cigna Group
Zimmer Biomet Holdings, Inc.
Moderna, Inc.
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.What are the scenarios for GSK?
An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.
What are the pros and cons of GSK?
How many points the write-up makes each way — a balance check, not a score or verdict.
- Strong profit margins on core products
- High return on equity showing efficient use of capital
- Relatively stable share price compared to the wider market
- Consistent history of paying dividends to shareholders
- Modest revenue growth compared to faster-moving sectors
- High reliance on the success of a few key drug patents
- Complex regulatory environment that can lead to unexpected costs
- Legal challenges related to past or current products
- Patent cliffs where generic competitors erode sales
- Failure of late-stage clinical trials to deliver results
The write-up's own warning lights — if these start happening, the case above changes.
- A sustained drop in the company's research and development success rate
- Major changes in government healthcare spending policies globally
Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-01 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.